REGISTERED NUMBER: 05683513 (England and Wales)

Laboratoire Biosthetique UK Limited

Unaudited Financial Statements

for the Year Ended 31 December 2024

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

D J Rippon (Resigned on 05.07.2025)

E K Hornigold

S H Weiser

REGISTERED OFFICE:

800 Wellworthy Road

Lymington

Hampshire

SO41 8JY

REGISTERED NUMBER:

05683513 (England and Wales)

Fixed assets

Intangible assets

5

34,500

51,750

Tangible assets

6

18,601

26,041

53,101

77,791

Current assets

Stocks

7

265,835

234,947

Debtors

8

238,227

283,405

Cash at bank

10,595

5,561

514,657

523,913

Creditors

Amounts falling due within one year

9

(298,822

)

(323,420

)

Net current assets

215,835

200,493

Total assets less current liabilities

268,936

278,284

Creditors

Amounts falling due after more than one year

10

(87,202

)

(97,550

)

Net assets

181,734

180,734

Capital and reserves

Called up share capital

12

10,000

10,000

Retained earnings

171,734

170,734

Shareholders' funds

181,734

180,734

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 December 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 December 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 29 September 2025 and were signed on its behalf by:

E K Hornigold - Director

1.	STATUTORY INFORMATION

Laboratoire Biosthetique UK Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2.	STATEMENT OF COMPLIANCE

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006.

3.	ACCOUNTING POLICIES

BASIS OF PREPARING THE FINANCIAL STATEMENTS

The financial statements have been prepared under the historical cost convention.

SIGNIFICANT JUDGEMENTS AND ESTIMATES

The principle accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all years presented, unless otherwise stated.

GOING CONCERN

The financial statements are prepared on a going concern basis.

TURNOVER

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

REVENUE RECOGNITION

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company's activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts and after eliminating sales within the company.

The company recognizes revenue when:

The amount of revenue can be reliably measured;

it is probable that future economic benefits will flow to the entity;

and specific criteria have been met for each of the company's activities.

GOODWILL

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition Over the company's interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

AMORTISATION

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class

Amortisation method and rate

Good will

Straight line over 10 years

INTANGIBLE ASSETS

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

TANGIBLE FIXED ASSETS

Tangible assets are stated in the statement of financial position at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Asset class

Depreciation method and rate

Fixtures, fittings and equipment

20% straight line basis

Computer equipment and furniture

33.33% straight line basis

Short leasehold land and building

10% straight line basis

STOCKS

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost is determined using the first-in, first-out (FIFO) method.

The cost of finished goods and work in progress comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the inventories to their present location and condition. At each reporting date, stocks are assessed for impairment. If stocks are impaired, the carrying amount is reduced to its selling price less costs to complete and sell; the impairment loss is recognised immediately in profit or loss.

TAXATION

Taxation for the year comprises current and deferred tax. Tax is recognised in the Statement of Income and Retained Earnings, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

DEFERRED TAX

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

FOREIGN CURRENCIES TRANSACTION AND BALANCES

Profit and loss account transactions in foreign currencies are translated into sterling at the exchange rate ruling at the date of the transaction. Monetary assets and liabilities denominated in foreign currencies are translated into sterling at the closing rates at the balance sheet date and the exchange differences are included in the profit and loss account.

CASH AND CASH EQUIVALENTS

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount Of cash and are subject to an insignificant risk of change in value.

TRADE DEBTORS

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

TRADE CREDITORS

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

BORROWINGS

Interest-bearing borrowings are initially recorded at fair value, net of transaction costs. Interest-bearing borrowings are subsequently carried at amortized cost, with the difference between the proceeds, net of transaction costs, and the amount due on redemption being recognised as a charge to the Profit and Loss Account over the period of the relevant borrowing.

Interest expense is recognised on the basis of the effective interest method and is included in interest payable and similar charges.

Borrowings ate classified as current liabilities unless the company has an unconditional right to defer settlement of the liability for at least twelve months after the reporting date.

SHARE CAPITAL

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

4.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

5.	INTANGIBLE FIXED ASSETS

Goodwill

£

COST

At 1 January 2024

and 31 December 2024

350,000

AMORTISATION

At 1 January 2024

298,250

Charge for year

17,250

At 31 December 2024

315,500

NET BOOK VALUE

At 31 December 2024

34,500

At 31 December 2023

51,750

6.	TANGIBLE FIXED ASSETS

Short

Fixtures

leasehold

Plant and

and

buildings

machinery

fittings

Totals

£

£

£

£

COST

At 1 January 2024

and 31 December 2024

74,399

14,458

2,797

91,654

DEPRECIATION

At 1 January 2024

48,358

14,458

2,797

65,613

Charge for year

7,440

-

-

7,440

At 31 December 2024

55,798

14,458

2,797

73,053

NET BOOK VALUE

At 31 December 2024

18,601

-

-

18,601

At 31 December 2023

26,041

-

-

26,041

7.

STOCKS

2024

2023

£

£

Stocks

265,835

234,947

8.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Trade debtors

205,012

229,064

Other debtors

23,683

54,341

Prepayments and accrued income

9,532

-

238,227

283,405

9.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2024

2023

£

£

Bank loans and overdrafts (see note 11)

10,353

10,096

Trade creditors

5,992

14,900

Amounts owed to group undertakings

200,207

155,966

Corporation tax liability

5,456

7,217

VAT

33,812

55,162

Other creditors

29,931

57,274

Accruals

13,071

22,805

298,822

323,420

10.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2024

2023

£

£

Bank loans (see note 11)

6,202

16,550

Directors' loan accounts

81,000

81,000

87,202

97,550

11.

LOANS

An analysis of the maturity of loans is given below:

2024

2023

£

£

Amounts falling due within one year or on demand:

Bank loans

10,353

10,096

Amounts falling due between two and five years:

Bank loans - 2-5 years

6,202

16,550

12.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2024

2023

value:

£

£

10,000

Ordinary

1

10,000

10,000

13.	OFF-BALANCE SHEET ARRANGEMENTS

Factored debts

Trade debtors include factored debts, which have not been paid to the factoring company. The factoring company has a charge over all factored debts. As at 31 December 2024, Laboratoire Biosthetique UK Limited owed the factoring company £29,931 (2023 : £57,274).

14.	RELATED PARTY DISCLOSURES

Summary of transactions with Other related parties

Shareholders

The company has an interest free loan of £81,000 (2023: £81,000) received from joint shareholders, one of whom is also a director of the company. The loan is not secured and does not have fixed repayment terms. It has been included within non-current liabilities.

The company has an interest free loan, of £200,207 (2023: £155,966) received from a shareholder. The loan is not secured and does not have fixed repayment terms. It has been included within current liabilities.